Leukemia Lymphoma Society Names Girl of the Year

Shaylah Saylor is named the Leukemia Lymphoma Society's Girl of the Year. The 11 year old girl has always dreamed of recording an album and Saturday, February 27, she got her wish. A group of women raising money to find a cure for leukemia, lymphoma, Hodgkin's Disease and myeloma and to improve the quality of life for patients and families who battle cancer helped organize the recording to honor Shaylah for her courage
Shaylah, whose blood cancer is in remission, recorded a CD with two songs that will be sold to raise money for the Leukemia and Lymphoma Society in fighting the disease.
The group -- dubbed Shaylah's Storm Troopers, The GI Jane Division -- is led by Diana Povis-Moore of Boiling Springs, Cumberland County. They hope to raise $50,000 during the next several weeks.
Shaylah inspired them to raise the funds, she said.
The team connected Shaylah with Kyle Betts, who has a recording studio in his Manchester Township home's basement.
Shaylah's mom says singing got Shayla through chemotherapy and she continues to work towards beating cancer. All proceeds from the album will go to the Leukemia Lymphoma Society. To purchase the CD or to donate to a fundraiser that will benefit the Leukemia and Lymphoma Society, call Diana Povis-Moore at 574-5516 or e-mail pdp43@msn.com.
To catch a video clip of Shaylah singing Carrie Underwood’s, “Jesus Take the Wheel,” go to:
http://www.yorkblog.com/mt/mt-search.cgi?IncludeBlogs=10&tag=Shaylah%20S...

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap